Mark DeLong

Insider Reports History

Entity
Individual
Location
100 5 Th Avenue, 3 Rd Floor, Waltham, MA
Signature
/s/ David Watson, attorney-in-fact for Mark DeLong
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark DeLong:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Apellis Pharmaceuticals, Inc. Chief Business & Strat Officer Stock Option (Right to Buy) 14.8K $981K $66.30 Aug 12, 2024 Direct
Apellis Pharmaceuticals, Inc. Chief Business & Strat Officer Common Stock 60.4K $836K $13.85 Aug 12, 2024 Direct

Insider Reports Filed by Mark DeLong

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APLS Apellis Pharmaceuticals, Inc. Aug 12, 2024 2 $72K 4 Aug 13, 2024 Chief Business & Strat Officer
APLS Apellis Pharmaceuticals, Inc. Mar 18, 2024 1 -$564K 4 Mar 19, 2024 Chief Business & Strat Officer
APLS Apellis Pharmaceuticals, Inc. Feb 12, 2024 1 -$40.5K 4 Feb 13, 2024 Chief Business & Strat Officer
APLS Apellis Pharmaceuticals, Inc. Jan 29, 2024 1 -$23.5K 4 Jan 31, 2024 Chief Business & Strat Officer
APLS Apellis Pharmaceuticals, Inc. Jan 22, 2024 1 -$90K 4 Jan 23, 2024 Chief Business & Strat Officer
APLS Apellis Pharmaceuticals, Inc. Jan 16, 2024 3 $1.53M 4 Jan 17, 2024 Chief Business & Strat Officer
APLS Apellis Pharmaceuticals, Inc. Oct 23, 2023 1 -$6.03K 4 Oct 24, 2023 Chief Business & Strat Officer
APLS Apellis Pharmaceuticals, Inc. Feb 21, 2023 3 -$25.8K 4 Feb 22, 2023 Chief Business & Strat Officer
APLS Apellis Pharmaceuticals, Inc. Feb 10, 2023 1 -$34.3K 4 Feb 14, 2023 Chief Business & Strat Officer
APLS Apellis Pharmaceuticals, Inc. Jan 27, 2023 1 -$19.4K 4 Jan 30, 2023 Chief Business & Strat Officer
APLS Apellis Pharmaceuticals, Inc. Jan 20, 2023 1 -$59.8K 4 Jan 24, 2023 Chief Business & Strat Officer
APLS Apellis Pharmaceuticals, Inc. Jan 12, 2023 2 $1.62M 4 Jan 17, 2023 Chief Business & Strat Officer
APLS Apellis Pharmaceuticals, Inc. Oct 20, 2022 1 -$11.4K 4 Oct 24, 2022 Senior Vice President
APLS Apellis Pharmaceuticals, Inc. Aug 17, 2022 3 -$270K 4 Aug 18, 2022 Senior Vice President
APLS Apellis Pharmaceuticals, Inc. Aug 11, 2022 3 -$257K 4 Aug 12, 2022 Senior Vice President
APLS Apellis Pharmaceuticals, Inc. Aug 8, 2022 3 -$245K 4 Aug 9, 2022 Senior Vice President
APLS Apellis Pharmaceuticals, Inc. Aug 4, 2022 4 -$452K 4 Aug 8, 2022 Senior Vice President
APLS Apellis Pharmaceuticals, Inc. Jul 27, 2022 3 -$207K 4 Jul 28, 2022 Senior Vice President
APLS Apellis Pharmaceuticals, Inc. Jul 19, 2022 3 -$205K 4 Jul 21, 2022 Senior Vice President
APLS Apellis Pharmaceuticals, Inc. Jun 16, 2022 3 -$279K 4 Jun 21, 2022 Senior Vice President
APLS Apellis Pharmaceuticals, Inc. Apr 20, 2022 3 -$259K 4 Apr 22, 2022 Senior Vice President
APLS Apellis Pharmaceuticals, Inc. Feb 10, 2022 3 -$12.8K 4 Feb 14, 2022 Senior Vice President
APLS Apellis Pharmaceuticals, Inc. Jan 28, 2022 1 -$16.7K 4 Feb 1, 2022 Senior Vice President
APLS Apellis Pharmaceuticals, Inc. Jan 21, 2022 2 $0 4/A Feb 7, 2022 Senior Vice President
APLS Apellis Pharmaceuticals, Inc. Oct 20, 2021 1 $0 4 Oct 27, 2021 Senior Vice President
APLS Apellis Pharmaceuticals, Inc. Jul 21, 2021 3 -$49.5K 4 Jul 22, 2021 Senior Vice President
APLS Apellis Pharmaceuticals, Inc. Jul 15, 2021 3 -$46.8K 4 Jul 16, 2021 Senior Vice President
APLS Apellis Pharmaceuticals, Inc. Jun 15, 2021 3 -$198K 4 Jun 16, 2021 Senior Vice President
APLS Apellis Pharmaceuticals, Inc. May 18, 2021 3 -$79K 4 May 19, 2021 Senior Vice President